Campbell & CO Investment Adviser LLC

Position in A — Agilent Technologies, Inc.

CIK 1353570 BALTIMORE, MD

Position in A

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,162,342

+$295,635 QoQ

Shares Held

89,159

+23.0% QoQ

Ownership

0.032%

of shares outstanding

% of Portfolio

0.58%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $54,655,619 across 18 Diagnostics & Research names. A ranks #1 (18.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	A	Agilent Technologies, Inc. This page	89,159	$10,162,342
2	DHR	Danaher Corp /De/	33,267	$6,307,423
3	WAT	Waters Corp /De/	16,002	$4,765,395
4	GH	Guardant Health, Inc.	48,547	$4,484,286
5	IDXX	Idexx Laboratories Inc /De	7,772	$4,367,009
6	TMO	Thermo Fisher Scientific Inc.	7,448	$3,660,915
7	CSTL	Castle Biosciences Inc	148,824	$3,653,629
8	VCYT	Veracyte, Inc.	106,443	$3,428,529

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,162,342	89,159	+23.0%	Shares	Sole	2026-05-15
2025-12-31	$9,866,707	72,512	+227.9%	Shares	Sole	2026-02-12
2025-03-31	$2,587,012	22,115	+141.8%	Shares	Sole	2025-05-14
2024-09-30	$1,357,849	9,145	+29.6%	Shares	Sole	2024-11-12
2023-09-30	$788,778	7,054	-55.7%	Shares	Sole	2023-11-08
2023-06-30	$1,914,861	15,924	-15.4%	Shares	Sole	2023-08-11
2023-03-31	$2,603,143	18,817	+106.4%	Shares	Sole	2023-05-11
2022-06-30	$1,082,588	9,115	+118.3%	Shares	Sole	2022-08-09
2022-03-31	$552,610	4,176	+129.7%	Shares	Sole	2022-05-09
2021-12-31	$290,243	1,818	-66.8%	Shares	Sole	2022-02-10
2021-09-30	$861,374	5,468	+152.2%	Shares	Sole	2021-11-10
2021-06-30	$320,452	2,168	+2.4%	Shares	Sole	2021-08-11
2020-09-30	$213,790	2,118	—	Shares	Sole	2020-10-15
No filing history on record for this holder in this stock.